Kamila Wójcik

463 total citations
33 papers, 255 citations indexed

About

Kamila Wójcik is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Kamila Wójcik has authored 33 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Infectious Diseases and 10 papers in Hepatology. Recurrent topics in Kamila Wójcik's work include Liver Disease Diagnosis and Treatment (11 papers), HIV/AIDS Research and Interventions (8 papers) and Hepatitis C virus research (8 papers). Kamila Wójcik is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), HIV/AIDS Research and Interventions (8 papers) and Hepatitis C virus research (8 papers). Kamila Wójcik collaborates with scholars based in Poland, United States and Australia. Kamila Wójcik's co-authors include Anna Piekarska, Elżbieta Jabłonowska, Bożena Szymańska, Ewa Siwak, Monika Bociąga‐Jasik, Miłosz Parczewski, Steven McPhail, Iwona Cielniak, Jörg C. Kalff and Ulrich Spengler and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Kamila Wójcik

31 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamila Wójcik Poland 10 138 81 69 42 37 33 255
Anela Kellogg United States 8 93 0.7× 116 1.4× 22 0.3× 14 0.3× 36 1.0× 8 264
Cinzia Balestrieri Italy 7 190 1.4× 35 0.4× 178 2.6× 37 0.9× 24 0.6× 16 384
Keith McCormick United Kingdom 5 127 0.9× 46 0.6× 32 0.5× 20 0.5× 13 0.4× 10 222
Tiejun Zhang China 8 106 0.8× 38 0.5× 36 0.5× 23 0.5× 57 1.5× 21 254
Xuefu Wu China 5 84 0.6× 26 0.3× 36 0.5× 24 0.6× 9 0.2× 7 132
Emanuela Messina Italy 10 116 0.8× 75 0.9× 104 1.5× 23 0.5× 23 0.6× 37 224
Maurizio D’Abbraccio Italy 7 48 0.3× 145 1.8× 23 0.3× 63 1.5× 34 0.9× 13 260
Maria Chini Greece 13 111 0.8× 129 1.6× 23 0.3× 85 2.0× 54 1.5× 41 367
Maria Caceres United States 6 88 0.6× 162 2.0× 13 0.2× 61 1.5× 16 0.4× 7 262
María Jesús Jiménez‐Expósito United States 8 162 1.2× 67 0.8× 163 2.4× 34 0.8× 7 0.2× 12 266

Countries citing papers authored by Kamila Wójcik

Since Specialization
Citations

This map shows the geographic impact of Kamila Wójcik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamila Wójcik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamila Wójcik more than expected).

Fields of papers citing papers by Kamila Wójcik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamila Wójcik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamila Wójcik. The network helps show where Kamila Wójcik may publish in the future.

Co-authorship network of co-authors of Kamila Wójcik

This figure shows the co-authorship network connecting the top 25 collaborators of Kamila Wójcik. A scholar is included among the top collaborators of Kamila Wójcik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamila Wójcik. Kamila Wójcik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wójcik, Kamila, Anna Piekarska, & Elżbieta Jabłonowska. (2024). Has COVID-19 Changed the Incidence and Profile of Late Presenters for HIV Infection in Lodz, Polish Reference Centre, Poland?. Journal of Clinical Medicine. 13(14). 4121–4121. 1 indexed citations
2.
Serwin, Karol, Antoine Chaillon, Anna Urbańska, et al.. (2023). Circulation of Human Immunodeficiency Virus 1 A6 Variant in the Eastern Border of the European Union—Dynamics of the Virus Transmissions Between Poland and Ukraine. Clinical Infectious Diseases. 76(10). 1716–1724. 15 indexed citations
3.
Jabłonowska, Elżbieta, Joanna Katarzyna Strzelczyk, Anna Piekarska, & Kamila Wójcik. (2021). Gut Microbiota Diversity in HIV-Infected Patients on Successful Antiretroviral Treatment is Linked to Sexual Preferences but not CD4 Nadir. Archivum Immunologiae et Therapiae Experimentalis. 69(1). 14–14. 5 indexed citations
4.
Wójcik, Kamila, et al.. (2019). NFE2L2 is associated with NQO1 expression and low stageof hepatic fibrosis in patients with chronic hepatitis C. Advances in Clinical and Experimental Medicine. 28(9). 1237–1241. 2 indexed citations
5.
Jabłonowska, Elżbieta, Ewa Siwak, Monika Bociąga‐Jasik, et al.. (2019). Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients. PLoS ONE. 14(1). e0210476–e0210476. 10 indexed citations
6.
Wójcik, Kamila, et al.. (2018). The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology. 4(1). 1–6. 61 indexed citations
7.
Wójcik, Kamila, Anna Piekarska, & Elżbieta Jabłonowska. (2018). Intestinal Barrier Impairment and Immune Activation in HIV-Infected Advanced Late Presenters are Not Dependent on CD4 Recovery. Archivum Immunologiae et Therapiae Experimentalis. 66(4). 321–327. 8 indexed citations
8.
Janik‐Koncewicz, Kinga, Jacek Gąsiorowski, Elżbieta Jabłonowska, et al.. (2017). Treatment of tobacco dependence among HIV-infected patients: rationale and preliminary actions taken in Poland. Journal of Health Inequalities. 1. 102–105. 2 indexed citations
9.
Wójcik, Kamila, et al.. (2017). E-046 Length of stay in mechanical thrombectomy, and machine learning improvement of predictive analysis. HighWire Press Open Archive. A64.1–A64. 1 indexed citations
10.
Jabłonowska, Elżbieta, Jacek Gąsiorowski, Miłosz Parczewski, et al.. (2017). Efficacy and safety of nucleoside‐sparing regimen based on raltegravir and ritonavir‐boosted darunavir in HIV‐1‐infected treatment‐experienced patients. Journal of Medical Virology. 89(12). 2122–2129. 9 indexed citations
11.
Wójcik, Kamila, Anna Piekarska, & Elżbieta Jabłonowska. (2016). Adherence to antiviral therapy in HIV or HBV-infected patients.. PubMed. 70(1). 27–32, 115. 5 indexed citations
12.
Jabłonowska, Elżbieta, Jacek Gąsiorowski, Miłosz Parczewski, et al.. (2016). Dual therapy based on raltegravir and boosted protease inhibitors – the experience of Polish centers. Archives of Medical Science. 14(4). 860–864. 2 indexed citations
13.
Wójcik, Kamila, Leigh U. Horsfall, Katharine M. Irvine, et al.. (2015). Patterns of service utilisation within hepatology clinics: high prevalence of advanced liver disease. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
14.
Broncel, Marlena, Kamila Wójcik, & Elżbieta Jabłonowska. (2015). Expanding role of single tablets regimens in selected therapeutic areas. 1 indexed citations
15.
Jabłonowska, Elżbieta, et al.. (2014). Hepatic HMOX1 Expression Positively Correlates with Bach-1 and miR-122 in Patients with HCV Mono and HIV/HCV Coinfection. PLoS ONE. 9(4). e95564–e95564. 10 indexed citations
16.
Jabłonowska, Elżbieta, Kamila Wójcik, & Anna Piekarska. (2013). Urine Liver-Type Fatty Acid-Binding Protein and Kidney Injury Molecule-1 in HIV-Infected Patients Receiving Combined Antiretroviral Treatment Based on Tenofovir. AIDS Research and Human Retroviruses. 30(4). 363–369. 11 indexed citations
17.
Jabłonowska, Elżbieta, Kamila Wójcik, & Marek Nocuń. (2012). The Influence of Treatment with Pegylated Interferon-Alfa and Ribavirin on Neutrophil Function and Death in Patients with HIV/HCV Coinfection. Viral Immunology. 25(2). 166–172. 3 indexed citations
18.
19.
Jabłonowska, Elżbieta, et al.. (2011). Neutrophil Function and Apoptosis in Patients with Chronic Hepatitis C Treated with Pegylated Interferon α and Ribavirin. Archivum Immunologiae et Therapiae Experimentalis. 60(1). 61–68. 2 indexed citations
20.
Wójcik, Kamila, et al.. (2006). [Brain abscess: analysis of prevalence and clinical course].. PubMed. 60(2). 265–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anela Kellogg Breakdown of academic impact, for papers by Cinzia Balestrieri Breakdown of academic impact, for papers by Keith McCormick Breakdown of academic impact, for papers by Tiejun Zhang Breakdown of academic impact, for papers by Xuefu Wu Breakdown of academic impact, for papers by Emanuela Messina Breakdown of academic impact, for papers by Maurizio D’Abbraccio Breakdown of academic impact, for papers by Maria Chini Breakdown of academic impact, for papers by Maria Caceres Breakdown of academic impact, for papers by María Jesús Jiménez‐Expósito
Rankless by CCL
2026